{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:11:53Z","timestamp":1778227913229,"version":"3.51.4"},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jtha.2025.10.024","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:43:58Z","timestamp":1762307038000},"page":"354-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protein S as a therapeutic target"],"prefix":"10.1016","volume":"24","author":[{"given":"Raja","family":"Prince Eladnani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Diab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2872-4863","authenticated-orcid":false,"given":"Anne","family":"Angelillo-Scherrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.10.024_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1021\/bi00623a022","article-title":"A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S","volume":"16","author":"Di Scipio","year":"1977","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2025.10.024_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0092-8674(95)90520-0","article-title":"The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3\/Axl family of receptor tyrosine kinases","volume":"80","author":"Stitt","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2025.10.024_bib3","doi-asserted-by":"crossref","first-page":"25750","DOI":"10.1074\/jbc.M114.569020","article-title":"Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation","volume":"289","author":"Tsou","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.10.024_bib4","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1073\/pnas.78.4.2512","article-title":"High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein","volume":"78","author":"Dahlback","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.10.024_bib5","doi-asserted-by":"crossref","first-page":"16788","DOI":"10.1016\/S0021-9258(19)85485-6","article-title":"Identification of residues 413-433 of plasma protein S as essential for binding to C4b-binding protein","volume":"268","author":"Fernandez","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.10.024_bib6","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1016\/S0021-9258(18)60959-7","article-title":"The protein S-binding site localized to the central core of C4b-binding protein","volume":"262","author":"Hillarp","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.10.024_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.148.1.207","article-title":"Human C4-binding protein. I. Isolation and characterization","volume":"148","author":"Scharfstein","year":"1978","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtha.2025.10.024_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1006\/geno.1994.1308","article-title":"The gene coding for the beta-chain of C4b-binding protein (C4BPB) has become a pseudogene in the mouse","volume":"21","author":"Rodriguez de Cordoba","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.jtha.2025.10.024_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0037-1604092","article-title":"Vitamin K-dependent protein S: beyond the protein C pathway","volume":"44","author":"Dahlback","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib10","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/j.febslet.2005.03.001","article-title":"The anticoagulant protein C pathway","volume":"579","author":"Dahlback","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jtha.2025.10.024_bib11","doi-asserted-by":"crossref","first-page":"16355","DOI":"10.1074\/jbc.M708985200","article-title":"Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V","volume":"283","author":"Gale","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.10.024_bib12","doi-asserted-by":"crossref","first-page":"27852","DOI":"10.1074\/jbc.270.46.27852","article-title":"Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C","volume":"270","author":"Rosing","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.10.024_bib13","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1016\/S0021-9258(19)70660-7","article-title":"Regulation of activated protein C by a new protein. A possible function for bovine protein S","volume":"255","author":"Walker","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.10.024_bib14","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.10.024_bib15","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2009-10-246686","article-title":"The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition","volume":"116","author":"Ndonwi","year":"2010","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2025.10.024_bib16","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S0049-3848(08)70021-5","article-title":"Protein S is a cofactor for tissue factor pathway inhibitor","volume":"122","author":"Rosing","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.10.024_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MOH.0000000000000838","article-title":"Tissue factor pathway inhibitor\u2014cofactor-dependent regulation of the initiation of coagulation","volume":"31","author":"Ahnstrom","year":"2024","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtha.2025.10.024_bib18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jtha.2023.01.033","article-title":"Natural anticoagulant discovery, the gift that keeps on giving: finding FV-Short","volume":"21","author":"Dahlback","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-0038-1650590","article-title":"The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S","volume":"76","author":"van Wijnen","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1160\/TH09-03-0152","article-title":"Identification of a protein S-interactive site within the A2 domain of the factor VIII heavy chain","volume":"102","author":"Takeyama","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib21","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/ATVBAHA.112.250928","article-title":"Inhibition of intrinsic Xase by protein S: a novel regulatory role of protein S independent of activated protein C","volume":"32","author":"Chattopadhyay","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.10.024_bib22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/ATVBAHA.117.310588","article-title":"Anticoagulant protein S targets the factor IXa heparin-binding exosite to prevent thrombosis","volume":"38","author":"Plautz","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.10.024_bib23","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1172\/JCI39325","article-title":"Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis","volume":"119","author":"Burstyn-Cohen","year":"2009","journal-title":"J Clin Inves"},{"key":"10.1016\/j.jtha.2025.10.024_bib24","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1083\/jcb.102.5.1971","article-title":"Participation of endothelial cells in the protein C-protein S anticoagulant pathway: the synthesis and release of protein S","volume":"102","author":"Stern","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jtha.2025.10.024_bib25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2018.00358","article-title":"Macrophage-derived protein S facilitates apoptotic polymorphonuclear cell clearance by resolution phase macrophages and supports their reprogramming","volume":"9","author":"Lumbroso","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.10.024_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.immuni.2013.06.010","article-title":"T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response","volume":"39","author":"Carrera Silva","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jtha.2025.10.024_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood.V70.1.301.301","article-title":"Biosynthesis and secretion of functional protein S by a human megakaryoblastic cell line (MEG-01)","volume":"70","author":"Ogura","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib28","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1182\/blood.V95.6.2008","article-title":"The anticoagulant factor, protein S, is produced by cultured human vascular smooth muscle cells and its expression is up-regulated by thrombin","volume":"95","author":"Benzakour","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/stem.2522","article-title":"Protein S regulates neural stem cell quiescence and neurogenesis","volume":"35","author":"Zelentsova","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.jtha.2025.10.024_bib30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.neuron.2012.10.015","article-title":"Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis","volume":"76","author":"Burstyn-Cohen","year":"2012","journal-title":"Neuron"},{"issue":"Pt 3","key":"10.1016\/j.jtha.2025.10.024_bib31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1042\/bj3020845","article-title":"Vitamin K-dependent protein S in Leydig cells of human testis","volume":"302","author":"Malm","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.jtha.2025.10.024_bib32","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1038\/s41467-022-33938-x","article-title":"Regulation of bone homeostasis by MERTK and TYRO3","volume":"13","author":"Engelmann","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.10.024_bib33","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.2019003630","article-title":"Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus","volume":"135","author":"Calzavarini","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib34","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.V66.6.1452.1452","article-title":"Identification and quantitation of protein S in human platelets","volume":"66","author":"Schwarz","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-230X(08)00002-X","article-title":"TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer","volume":"100","author":"Linger","year":"2008","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.jtha.2025.10.024_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12964-019-0461-0","article-title":"TAM receptors, phosphatidylserine, inflammation, and cancer","volume":"17","author":"Burstyn-Cohen","year":"2019","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jtha.2025.10.024_bib37","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1074\/jbc.271.16.9785","article-title":"Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl","volume":"271","author":"Mark","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.10.024_bib38","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1074\/jbc.M311750200","article-title":"Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl\/Tyro3 receptor tyrosine kinase family","volume":"279","author":"Heiring","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.10.024_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.1061663","article-title":"Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family","volume":"293","author":"Lu","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jtha.2025.10.024_bib40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mcn.2006.06.011","article-title":"TAM receptor function in the retinal pigment epithelium","volume":"33","author":"Prasad","year":"2006","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.jtha.2025.10.024_bib41","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM receptors are pleiotropic inhibitors of the innate immune response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2025.10.024_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0140-6736(90)90201-F","article-title":"Neonatal purpura fulminans associated with homozygous protein S deficiency","volume":"335","author":"Mahasandana","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.10.024_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0037-1614440","article-title":"Compound heterozygosity for one novel and one recurrent mutation in a Thai patient with severe protein S deficiency","volume":"81","author":"Pung-amritt","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib44","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM198412133112401","article-title":"Recurrent venous thromboembolism in patients with a partial deficiency of protein S","volume":"311","author":"Comp","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.10.024_bib45","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood.V64.6.1297.1297","article-title":"Plasma protein S deficiency in familial thrombotic disease","volume":"64","author":"Schwarz","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2141.2008.07339.x","article-title":"Does thrombophilia testing help in the clinical management of patients?","volume":"143","author":"Middeldorp","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.10.024_bib47","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jama.2025.0155","article-title":"Population-scale studies of protein S abnormalities and thrombosis","volume":"333","author":"Chaudhry","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.10.024_bib48","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2009-03-209031","article-title":"Generation and phenotypic analysis of protein S-deficient mice","volume":"114","author":"Saller","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib49","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood-2017-09-800326","article-title":"Targeting anticoagulant protein S to improve hemostasis in hemophilia","volume":"131","author":"Prince","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib50","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2024-208020","article-title":"A phase 1a study of VGA039, a protein S-targeting monoclonal antibody, in individuals with von Willebrand disease demonstrates concentration-dependent increases in thrombin generation for reducing bleeding","volume":"144","author":"Millar","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib51","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/jth.15736","article-title":"Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein S","volume":"20","author":"Sedzro","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib52","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.jtha.2025.03.021","article-title":"Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S","volume":"23","author":"Eladnani","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib53","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2022-170245","article-title":"Pre-clinical characterization of VGA039, an anti-protein S monoclonal antibody being developed as a universal hemostatic agent for various bleeding disorders","volume":"140","author":"Leong","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib54","article-title":"The anti-protein S antibody VGA039 enhances ex vivo coagulation as assessed by thromboelastometry. 2025 Congress of the International Society of Thrombosis and Haemostasis (Washington)","volume":"9","author":"Moser","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib55","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1172\/JCI117883","article-title":"Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits","volume":"95","author":"Arnljots","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.10.024_bib56","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/rth2.12420","article-title":"Camelid-derived single-chain antibodies in hemostasis: mechanistic, diagnostic, and therapeutic applications","volume":"4","author":"Peyron","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib57","doi-asserted-by":"crossref","first-page":"36187","DOI":"10.1074\/jbc.274.51.36187","article-title":"C-terminal residues 621-635 of protein S are essential for binding to factor Va","volume":"274","author":"Heeb","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.10.024_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.10.024_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2022.100018","article-title":"Thrombin generation and implications for hemophilia therapies: a narrative review","volume":"7","author":"Sidonio","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib60","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/hae.13860","article-title":"Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia","volume":"25","author":"Ellery","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.10.024_bib61","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0037-1615679","article-title":"Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors","volume":"85","author":"Escuriola Ettingshausen","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2009.11.003","article-title":"Factor V Leiden and hemophilia","volume":"125","author":"Franchini","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.10.024_bib63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0029-1222609","article-title":"Interpatient phenotypic inconsistency in severe congenital hemophilia: a systematic review of the role of inherited thrombophilia","volume":"35","author":"Franchini","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib64","first-page":"9","article-title":"Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay","volume":"7","author":"Ghosh","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.10.024_bib65","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3324\/haematol.11161","article-title":"Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children\u2014results of a multicenter studys","volume":"92","author":"Kurnik","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.10.024_bib66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613824","article-title":"Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A","volume":"83","author":"Lee","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib67","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood.V81.3.690.690","article-title":"Increased thrombin generation in a child with a combined factor IX and protein C deficiency","volume":"81","author":"Negrier","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib68","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2141.2007.06693.x","article-title":"Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients","volume":"138","author":"Shetty","year":"2007","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.jtha.2025.10.024_bib69","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1365-2516.2002.00623.x","article-title":"Modifier genes in haemophilia: their expansion in the human genome","author":"Tizzano","year":"2002","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.10.024_bib70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2516.2004.00906.x","article-title":"Haemophilia and thrombophilia: an unexpected association","volume":"10","author":"Dargaud","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.10.024_bib71","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000911","article-title":"Nonfactor therapies for hemophilia","volume":"7","author":"Young","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.jtha.2025.10.024_bib72","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1616569","article-title":"Targeting of antithrombin in hemophilia A or B with RNAi therapy","volume":"377","author":"Pasi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.10.024_bib73","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/bloodadvances.2024013900","article-title":"Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management, in people with hemophilia A or B","volume":"9","author":"Pipe","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.10.024_bib74","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S2352-3026(23)00037-6","article-title":"Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A\/B): a multicentre, open-label, randomised, phase 3 trial","volume":"10","author":"Srivastava","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.10.024_bib75","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40265-023-01912-6","article-title":"Concizumab: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jtha.2025.10.024_bib76","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/rth2.12438","article-title":"MG1113, a specific anti-tissue factor pathway inhibitor antibody, rebalances the coagulation system and promotes hemostasis in hemophilia","volume":"4","author":"Kwak","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib77","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/bjh.18495","article-title":"Long-term safety and efficacy of the anti-tissue factor pathway inhibitor marstacimab in participants with severe haemophilia: Phase II study results","volume":"200","author":"Mahlangu","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.10.024_bib78","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2216455","article-title":"Phase 3 trial of concizumab in hemophilia with inhibitors","volume":"389","author":"Matsushita","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.10.024_bib79","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1182\/blood.2019001542","article-title":"Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A\/B with inhibitors: phase 2 trial results","volume":"134","author":"Shapiro","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib80","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/blood-2016-05-718635","article-title":"Design and characterization of an APC-specific serpin for the treatment of hemophilia","volume":"129","author":"Polderdijk","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib81","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood.2023020005","article-title":"Safety and efficacy of an anti-human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models","volume":"142","author":"Jiang","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib82","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1038\/s41467-020-16720-9","article-title":"Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.10.024_bib83","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/09537104.2019.1581922","article-title":"Platelets compensate for poor thrombin generation in type 3 von Willebrand disease","volume":"31","author":"Szanto","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2025.10.024_bib84","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jth.15444","article-title":"Hemophilic arthropathy: current knowledge and future perspectives","volume":"19","author":"Gualtierotti","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib85","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/jth.14242","article-title":"Nano-evidence for joint microbleeds in hemophilia patients","volume":"16","author":"Puetz","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/jcm6070063","article-title":"Pathophysiology of Hemophilic Arthropathy","volume":"6","author":"Melchiorre","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2025.10.024_bib87","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.032","article-title":"Pathophysiology of hemophilic arthropathy and potential targets for therapy","volume":"115","author":"Pulles","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jtha.2025.10.024_bib88","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1538-7836.2010.03962.x","article-title":"Blood-induced joint disease: the pathophysiology of hemophilic arthropathy","volume":"8","author":"Valentino","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib89","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.joca.2014.09.008","article-title":"Biochemical markers of joint tissue damage increase shortly after a joint bleed; an explorative human and canine in vivo study","volume":"23","author":"van Vulpen","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl 3","key":"10.1016\/j.jtha.2025.10.024_bib90","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/hae.14025","article-title":"Synovitis and synovectomy in haemophilia","volume":"27","author":"van Vulpen","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.10.024_bib91","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/hae.14565","article-title":"Bone health in haemophilia carriers and persons with von Willebrand disease: a large database analysis","volume":"28","author":"Citla-Sridhar","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.10.024_bib92","article-title":"Low bone mineral density in hemophiliacs","volume":"9","author":"Gebetsberger","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtha.2025.10.024_bib93","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2516.2008.01963.x","article-title":"Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia","volume":"15","author":"Gerstner","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.10.024_bib94","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1160\/TH09-09-0629","article-title":"Bone mineral density in haemophilia patients. A meta-analysis","volume":"103","author":"Iorio","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib95","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2516.2008.01912.x","article-title":"Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density","volume":"15","author":"Khawaji","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.10.024_bib96","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.transci.2007.12.003","article-title":"Hemophilia, low bone mass, and osteopenia\/osteoporosis","volume":"38","author":"Kovacs","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtha.2025.10.024_bib97","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1182\/blood-2014-10-602060","article-title":"Premature changes in trabecular and cortical microarchitecture result in decreased bone strength in hemophilia","volume":"125","author":"Lee","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.10.024_bib98","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1756-185X.2009.01394.x","article-title":"Reduced bone density in individuals with severe hemophilia B","volume":"12","author":"Mansouritorghabeh","year":"2009","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jtha.2025.10.024_bib99","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1007\/s00198-014-2773-7","article-title":"Bone mineral density in men and children with haemophilia A and B: a systematic review and meta-analysis","volume":"25","author":"Paschou","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jtha.2025.10.024_bib100","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/hae.15056","article-title":"Self-conducted sonographic monitoring of the knee in patients with haemophilia\u2014a feasibility study","volume":"30","author":"Strauss","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.10.024_bib101","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1111\/hae.14208","article-title":"Ultrasound and patient self-imaging in hemophilia","volume":"27","author":"von Drygalski","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.10.024_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102624","article-title":"The influence of severity of hemophilia on bone mineral density and fracture risk","volume":"8","author":"Ransmann","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib103","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bjh.13312","article-title":"Increased fracture rates in people with haemophilia: a 10-year single institution retrospective analysis","volume":"170","author":"Gay","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.10.024_bib104","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/ijms25010233","article-title":"The role of TAM receptors in bone","volume":"25","author":"Engelmann","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.10.024_bib105","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/rheumatology\/key337","article-title":"The level of synovial AXL expression determines the outcome of inflammatory arthritis, possibly depending on the upstream role of TGF-beta1","volume":"58","author":"Waterborg","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtha.2025.10.024_bib106","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.4049\/jimmunol.1200662","article-title":"Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction","volume":"189","author":"Zizzo","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jtha.2025.10.024_bib107","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1074\/jbc.273.12.7123","article-title":"GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells","volume":"273","author":"Fridell","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.10.024_bib108","first-page":"3141","article-title":"Relationship between PI3K pathway and angiogenesis in CIA rat synovium","volume":"8","author":"Zou","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jtha.2025.10.024_bib109","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41467-024-46564-6","article-title":"Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritis","volume":"15","author":"Nerviani","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.10.024_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau0964","article-title":"Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches","volume":"363","author":"Chakarov","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jtha.2025.10.024_bib111","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf7777","article-title":"Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles","volume":"7","author":"Dick","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jtha.2025.10.024_bib112","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard-2022-222773","article-title":"Synovial fibroblasts assume distinct functional identities and secrete R-spondin 2 in osteoarthritis","volume":"82","author":"Knights","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtha.2025.10.024_bib113","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/annrheumdis-2012-202907","article-title":"Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis","volume":"73","author":"Ruiz-Heiland","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtha.2025.10.024_bib114","article-title":"Genetic ablation of anticoagulant protein S promotes joint health in hemophilia A. 2024 Congress of the International Society of Thrombosis and Haemostasis (Bangkok) OC 21.4","volume":"88","author":"Prince-Eladnani","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.024_bib115","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1016\/j.jtha.2025.06.035","article-title":"Enzymatic modifications of protein S: cause and impact on diagnostics, plasma processing, and anticoagulant properties","volume":"23","author":"Brinkman","year":"2025","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362500724X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362500724X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:22:57Z","timestamp":1778224977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362500724X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S153878362500724X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.10.024","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein S as a therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}